It really pisses me off after all the positive publicity Leronlimab has gotten over the last few months, that a professor of medicine can’t even include it in their article on Yahoo. Hopefully, this will change with trial results pending.


https://www.yahoo.com/news/drugs-therapies-pr...14199.html